Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000807249-23-000136
Filing Date
2023-10-19
Accepted
2023-10-19 16:07:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 cyt_00.htm SC 13D 173902
  Complete submission text file 0000807249-23-000136.txt   175664
Mailing Address 191 MASON STREET GREENWICH CT 06830
Business Address 191 MASON STREET GREENWICH CT 06830 9149215000
GAMCO INVESTORS, INC. ET AL (Filed by) CIK: 0000807249 (see all company filings)

EIN.: 133056041 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SC 13D
SIC: 0000

Mailing Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Subject) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92616 | Film No.: 231334813
SIC: 2834 Pharmaceutical Preparations